• Welcome to FZATA
  • News & Events

    Research article on FZ002 was published in Science Translational Medicine

    November 6, 2020

    Our first-in-class yeast based immunotherapy for C. diff infection was recently published in the Science Translational Medicine. The novelty and great potential of our platform and product have been reported by Science magazine, BioTechScope and MedicalExpress etc.

    https://lnkd.in/ePh5ef2

    https://lnkd.in/ea2nWva

    https://lnkd.in/eAKhtdK